> Cardiores > ASPirin in Reducing Events in the Elderly (ASPREE) ASPREE is a 5 year primary prevention clinical trial aimed at assessing whether daily treatment of aspirin prolongs healthy lifespan through the prevention of heart attack, stroke, cognitive decline, physical decline and some cancers such as bowel cancer.